Table 1.
Group | Cases | Mean Age at Death (years)* | Sex | Mean PMI (hours)* | Neuropathology | APOE genotype |
---|---|---|---|---|---|---|
Down syndrome | 20 | 59.8 ± 4.99 | 7 F / 13 M | 17.95 ± 11.71 | Equivalent to A3, B3, C3 score or Braak V-VI, Thal 5 | ε3/ε3: 13, ε4/ε4: 2, ε3/ε4: 3, ε2/ε4: 1 |
EOAD | 20 | 63 ± 4.07 | 5 F / 15 M | 27.47 ± 12.76 | Equivalent to A3, B3, C3 score or Braak V-VI, Thal 4 | ε3/ε3: 10, ε4/ε4: 3, ε3/ε4: 5, ε2/ε3: 2 |
LOAD | 20 | # 82.1 ± 6.37 | 10 F / 10 M | 33.22 ± 19.19 | A3, B3, C3 or Braak VI | ε3/ε3: 6, ε4/ε4: 3, ε3/ε4: 7, ε2/ε3: 2, ε2/ε4: 2 |
Control | 20 | 66.4 ± 13.04 | 9 F / 11 M | 59.50 ± 27.30 | ≤ A1, B1, C1 | N/A |
Mean Age at death and Mean PMI ± Standard deviation.
Significant differences by one-way ANOVA.